0001140361-23-031424.txt : 20230628
0001140361-23-031424.hdr.sgml : 20230628
20230628160202
ACCESSION NUMBER: 0001140361-23-031424
CONFORMED SUBMISSION TYPE: 13F-HR/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20230626
DATE AS OF CHANGE: 20230628
EFFECTIVENESS DATE: 20230626
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: METLIFE INC
CENTRAL INDEX KEY: 0001099219
STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311]
IRS NUMBER: 134075851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18621
FILM NUMBER: 231052084
BUSINESS ADDRESS:
STREET 1: 200 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10166
BUSINESS PHONE: 212-578-5500
MAIL ADDRESS:
STREET 1: 200 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10166
13F-HR/A
1
primary_doc.xml
X0202
13F-HR/A
LIVE
0001099219
XXXXXXXX
06-30-2020
06-30-2020
true
2
NEW HOLDINGS
METLIFE INC
200 PARK AVENUE
NEW YORK
NY
10166
13F COMBINATION REPORT
028-18621
0000931588
028-16107
PROVIDA PENSION FUND ADMINISTRATOR
0000728618
028-00491
METROPOLITAN LIFE INSURANCE CO/NY
0001529735
028-18628
000142463
801-67314
MetLife Investment Management, LLC
Y
This amendment adds a new holdings entry of security that was inadvertently omitted in the 13F Combination Report filed for this quarter, as amended by the 13F amendment filed on June 26, 2023. MetLife, Inc. is the parent holding company of certain institutional investment managers. For purposes of the reporting requirements under Section 13(f) of the Securities Exchange Act of 1934 (the Act), and the rules promulgated thereunder, MetLife, Inc. itself does not exercise, and therefore disclaims, investment discretion with respect to any Section 13(f) securities positions over which its investment operating subsidiaries exercise such discretion. To the extent, however, that MetLife Inc.'s ownership interest in such subsidiaries may nevertheless give rise to a Form 13F obligation on behalf of MetLife, Inc., the information required by Form 13F is reported herein on behalf of all such subsidiaries.
Steven Goulart
EVP & Chief Investment Officer
973-355-4814
/s/ Steven Goulart
WHIPPANY
NJ
06-26-2023
0
1
11399959
INFORMATION TABLE
2
informationtable.xml
CELLCOM ISRAEL LTD
SHS
M2196U109
11399959
196385
SH
DFND
0
196385
0